Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06823037

HAPPI Hormonal Contraception Access Through Pharmacist Prescribing Implementation Phase 2 Aim 1

Led by EMPOWERX INC · Updated on 2025-12-04

150

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

E

EMPOWERX INC

Lead Sponsor

P

Purdue University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether using the HAPPI software can improve how pharmacists provide birth control services and how easily patients can access these services. This trial focuses on comparing pharmacist implementation and patient access with and without the HAPPI software to see if it offers improvements. The study involves 15 community pharmacies that will first continue their usual birth control services for several months without the software. Then, the HAPPI software will be introduced to replace previous paper or electronic processes as pharmacists continue providing birth control services. Outcomes during the control and intervention periods will be compared. Participants include pharmacists who provide birth control services and patients who receive these services at participating pharmacies. Researchers will measure aspects such as the number of pharmacists and pharmacy staff involved, payment methods like cash or insurance billing, and overall access to care during the study period of up to 5 months. The study is sponsored by EMPOWERX INC and runs through August 2026.

CONDITIONS

Brief Title

Hormonal Contraception Access Through Pharmacist Prescribing Implementation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pharmacists must be 18 years or older
  • Pharmacists provide birth control services in a participating pharmacy
  • Pharmacists use the HAPPI software to provide birth control services
  • Patients must be 18 years or older
  • Patients seek birth control services at a participating pharmacy
  • Patients use the HAPPI software to receive birth control services at a participating pharmacy
Not Eligible

You will not qualify if you...

  • None for pharmacists
  • None for patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or virtual) to confirm eligibility

Control Period

Duration - Several months

Participants receive birth control services as usual without the HAPPI software.

Participants receive routine pharmacy visits as needed for birth control services

Intervention Period

Duration - Several months

Participants receive birth control services using the HAPPI software instead of previous paper or electronic processes.

Participants receive routine pharmacy visits as needed for birth control services using the software

Trial Site Locations

Total: 1 location

1

EmpoweRx, Inc

Del Mar, California, United States, 92014

Actively Recruiting

Loading map...

Research Team

J

Jenny L Newlon, PharmD, PhD

S

Sally Rafie, PharmD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

1

Similar Trials

A Randomized, Single-Masked, 3-Way Crossover Study to Evalua...

Contraception

Actively Recruiting

3 locations

A Single Arm, Open-Label Pivotal Contraceptive Efficacy Stud...

Contraception

Actively Recruiting

27 locations

Drospirenone Only Pills and Cervical Mucus Changes in Obese ...

Contraception

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Determining user implementation needs for pharmacist-prescribed contraception using concept mapping: A participatory, multiple stakeholder approach.

Jenny L Newlon, Jennifer A Campi, Sally Rafie...

https://pubmed.ncbi.nlm.nih.gov/39512515